Issues and legislation related to U.S. investment in pathogen surveillance as pertains to national security and National Defense Authorization Act (NDAA); issues and legislation related to government funding for health care agencies.
2025 · 3rd Quarter (July 1 - Sep 30)
ACTUM OBO ILLUMINA, INC.
Filed by S-3 GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Termination
- Posted
- Jan 13, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- S-3 GROUP
- Client
- ACTUM OBO ILLUMINA, INC.
- Filing UUID
- 52f84940-669c-4ebb-a8e3-2a09af049e4d
- Termination date
- Jul 1, 2025
Literal source text
Lobbying issues and bill citations
Issues and legislation related to tax reform and corporate tax policy
General discussion and monitoring of U.S. trade policy
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.